Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities

Daily Values

Growth Metrics

Others

Apyx Medical (APYX) Treasury Shares (2023 - 2024)

Historic Treasury Shares for Apyx Medical (APYX) over the last 2 years, with Q4 2024 value amounting to $2.1 million.

Apyx Medical's Treasury Shares rose 315.53% to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year increase of 315.53%. This contributed to the annual value of $2.1 million for FY2024, which is 315.53% up from last year.
Per Apyx Medical's latest filing, its Treasury Shares stood at $2.1 million for Q4 2024, which was up 315.53% from $2.1 million recorded in Q4 2023.
Over the past 5 years, Apyx Medical's Treasury Shares peaked at $2.1 million during Q4 2024, and registered a low of $2.1 million during Q4 2023.